Regulated information
March 12, 2012
TiGenix to announce 2011 results on March 15
CORRECTION: conference call start time 14:00 CET
Leuven (BELGIUM) - March 12, 2012 - TiGenix (NYSE Euronext: TIG) announced today that the Company's March 15 conference call to discuss the full-year 2011 results and provide a business update will start at 14:00 CET and not 15:00 as was previously announced
The timing of the distribution of the full-year 2011 results press release remains unchanged at 7:00 CET on March 15.
Title: TiGenix Full-Year 2011 Financial Results
Date: March 15, 2012
Time: 14:00 CET (13:00 GMT/8:00 EST)
To participate, please listen to the webcast or call one of the following telephone numbers.
International dial-in numbers:
+32 2 620 0138 Belgium
+34 91 791 7146 Spain
+31 20 721 9158 Netherlands
+44 20 3106 4822 UK
+1 646 254 3388 USA
For more information:
Hans Herklots
Director Investor & Media Relations
hans.herklots@tigenix.com
+32 16 39 60 97
About TiGenix
TiGenix NV (NYSE Euronext Brussels: TIG) is a leading European cell therapy company with two marketed products for cartilage repair, and a strong pipeline with clinical stage allogeneic adult stem cell programs for the treatment of autoimmune and inflammatory diseases. TiGenix is based out of Leuven (Belgium) and has operations in Madrid (Spain), Cambridge (UK) and Sittard-Geleen (the Netherlands). For more information please visit www.tigenix.com.